Emerging targets of inflammation and tear secretion in dry eye disease

Area of Science:

• Ophthalmology
• Dry Eye Disease Pathophysiology

Background:

• Dry eye disease (DED) is characterized by a vicious cycle initiated by hyperosmolarity.
• This cycle involves inflammation, loss of ocular surface mucins, and epithelial cell damage, leading to tear film instability.

Purpose of the Study:

• To review emerging therapeutic strategies for dry eye management.
• Focus on treatments that promote tear secretion and control inflammation.

Main Methods:

• Literature review of current and emerging dry eye therapies.
• Analysis of mechanisms underlying DED and treatment approaches.

Main Results:

• Current treatments for DED are often palliative and require frequent application.
• Emerging therapies aim to address the root causes of DED by restoring homeostasis.

Conclusions:

• Effective dry eye management requires breaking the inflammatory cycle.
• Novel approaches targeting tear secretion and inflammation show promise for long-term relief.